Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing‑remitting multiple sclerosis to natalizumab treatment
Journal article published in 2019 by
Paolo Fagone,
Emanuela Mazzon 
,
Santa Mammana,
Roberto Di Marco,
Flaminia Spinasanta,
Maria Basile,
Maria Petralia,
Placido Bramanti,
Ferdinando Nicoletti,
Katia Mangano
,
Santa Mammana,
Roberto Di Marco,
Flaminia Spinasanta,
Maria Basile,
Maria Petralia,
Placido Bramanti,
Ferdinando Nicoletti,
Katia Mangano
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Data provided by 